Impact of a Mobile Application-Based Medication Reminder on Treatment Adherence Among Patients With Chronic Diseases and Memory Impairment: A Nursing Leadership Perspective
2026年7月18日 更新者：Asmaa Elwan Mohammed Hassan、Mansoura University
Impact of a Mobile Application-Based Medication Reminder on Treatment Adherence Among Patients With Chronic Diseases and Memory Impairment: A Nursing Leadership Perspective - A Quasi Experimental Study
This study aims to evaluate the impact of using a mobile application-based medication reminder on medication adherence among patients diagnosed with chronic diseases and memory impairment.
Adherence to prescribed therapy is a significant challenge for this patient population, often leading to poor health outcomes and increased healthcare costs.
From a nursing leadership perspective, innovative digital solutions can play a crucial role in supporting patient self-management.
Using a quasi-experimental design, the study will investigate whether a customized mobile reminder system can effectively improve adherence rates and support patients in managing their therapeutic regimens.
研究概览
详细说明
Improving medication adherence in patients with chronic illnesses and cognitive decline is a key priority in healthcare management and nursing administration. This quasi-experimental study utilizes a pretest-posttest design to examine the effectiveness of a mobile application-based reminder system designed specifically for patients experiencing memory impairment.
Participants will be selected based on specific inclusion criteria, including being diagnosed with a chronic disease and exhibiting mild-to-moderate memory impairment. Baseline assessments (pretest) will be conducted to measure initial medication adherence levels, patient demographics, and health status. Following the baseline phase, the intervention will be introduced, where participants will utilize the mobile application to receive automated medication alerts and reminders over a specified period. Evaluation (posttest) will be performed post-intervention to analyze changes in adherence rates. The findings are expected to provide insights into how nursing leadership can leverage mobile health (mHealth) technology to design supportive care pathways, enhance patient independence, and reduce clinical complications associated with poor treatment adherence.
研究类型
介入性
注册 (估计的)
193
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习联系方式
- 姓名：Asmaa Elwan Hassan, PhD
- 电话号码：+201063776424
- 邮箱：asmaaelwan@mans.edu.eg
研究联系人备份
- 姓名：Mona Ahmed Gabr, PhD
- 电话号码：201097898593
学习地点
-
-
Dakahlia Governorate
-
Gamasa、Dakahlia Governorate、埃及
- 招聘中
- Outpatient Clinics, Delta University for Science and Technology
-
接触：
- Asmaa Elwan Hassan, PhD
- 电话号码：+201063776424
- 邮箱：asmaaelwan@mans.edu.eg
-
接触：
- Mona Ahmed Gabr, PhD
-
-
Kafr el-Sheikh Governorate
-
Kafr ash Shaykh、Kafr el-Sheikh Governorate、埃及
- 招聘中
- Outpatient Clinics, Kafr El-Sheikh Hospital
-
接触：
- Asmaa Elwan Hassan, PhD
- 电话号码：+201063776424
- 邮箱：asmaaelwan@mans.edu.eg
-
接触：
- Mona Ahmed Gabr, PhD
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Patients diagnosed with one or more chronic diseases requiring regular long-term medication.
- Patients exhibiting mild-to-moderate memory impairment or cognitive decline as screened by the Mini-Mental State Examination (MMSE).
- Patients who personally own and are capable of operating a smartphone or have a primary caregiver willing to manage the mobile application.
- Patients aged 18 years and older.
- Patients who provide voluntary informed consent to participate in the study.
Exclusion Criteria:
- Patients with severe cognitive impairment or advanced dementia who cannot interact with mobile technology even with caregiver assistance.
- Patients with severe acute clinical complications or unstable psychiatric conditions.
- Patients participating in another concurrent clinical trial or study targeting medication adherence
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：支持治疗
- 分配：不适用
- 介入模型：单组作业
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Mobile Application Group
Participants in this single-group study will receive training on and utilize a customized mobile application-based medication reminder designed to support adherence to their therapeutic regimens.
|
The intervention consists of a mobile application specifically designed to support medication adherence.
It features automated push notifications, customized reminder alerts matching prescribed medication schedules, and tracking logs.
Participants will be instructed on how to install, configure, and use the application on their personal smartphones.
The system is designed to provide immediate prompts to overcome memory-related adherence barriers.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Medication Adherence (MMAS-8)
大体时间：Baseline (pre-intervention) and 3 months post-intervention
|
Medication adherence will be assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8).
This self-reported tool evaluates patients' behaviors regarding taking their prescribed chronic medications.
Total scores range from 0 to 8, where a score of 8 indicates high adherence, 6 to <8 indicates medium adherence, and <6 indicates low adherence.
|
Baseline (pre-intervention) and 3 months post-intervention
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Objective Medication Adherence: Medication Possession Ratio (MPR)
大体时间：3 months post-intervention
|
Medication Possession Ratio (MPR) will be calculated using pharmacy refill records to determine the proportion of time the patient has access to their prescribed medication during the study period.
Total scores will range from 0 to 1 (or 0% to 100%), with higher values indicating better adherence.
|
3 months post-intervention
|
|
Objective Medication Adherence: Proportion of Days Covered (PDC)
大体时间：3 months post-intervention
|
Proportion of Days Covered (PDC) will be assessed using pharmacy refill records to measure the percentage of days the patient covered their prescribed medication dosage over the study duration.
Total scores will range from 0 to 1 (or 0% to 100%), where higher values reflect superior medication adherence.
|
3 months post-intervention
|
|
Cognitive Function Status (MMSE)
大体时间：Baseline
|
Cognitive impairment levels will be screened using the Mini-Mental State Examination (MMSE) to classify the severity of cognitive/memory impairment among participants.
|
Baseline
|
|
Perceived Nursing Care and Leadership Support
大体时间：3 months post-intervention.
|
Evaluated using the Nursing Care and Leadership Support Assessment Tool to measure patient satisfaction and perception of the supportive role played by nursing leadership during the application-based program.
|
3 months post-intervention.
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2026年5月10日
初级完成 (估计的)
2026年9月1日
研究完成 (估计的)
2026年9月1日
研究注册日期
首次提交
2026年7月14日
首先提交符合 QC 标准的
2026年7月18日
首次发布 (实际的)
2026年7月21日
研究记录更新
最后更新发布 (实际的)
2026年7月21日
上次提交的符合 QC 标准的更新
2026年7月18日
最后验证
2026年7月1日
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- DFM-IRB 00012367- 26-04-001
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
不
IPD 计划说明
Individual participant data will not be shared to ensure the confidentiality and privacy of the patients' medical records and personal information.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.